Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis.
Blobner J, Dengler L, Eberle C, Herold JJ, Xu T, Beck A, Mühlbauer A, Müller KJ, Teske N, Karschnia P, van den Heuvel D, Schallerer F, Ishikawa-Ankerhold H, Thon N, Tonn JC, Subklewe M, Kobold S, Harter PN, Buchholz VR, von Baumgarten L. Blobner J, et al. Among authors: harter pn. Cancer Immunol Immunother. 2024 Oct 3;73(12):255. doi: 10.1007/s00262-024-03837-9. Cancer Immunol Immunother. 2024. PMID: 39358663 Free PMC article.
Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma.
Blobner J, Dengler L, Blobner S, Eberle C, Weller J, Teske N, Karschnia P, Rühlmann K, Heinrich K, Ziemann F, Greif PA, Jeremias I, Wuerstlein R, Hasselmann K, Dorostkar M, Harter PN, Quach S, Stoecklein V, Albert NL, Niyazi M, Tonn JC, Thon N, Christoph Westphalen B, von Baumgarten L. Blobner J, et al. Among authors: harter pn. Neurooncol Adv. 2023 May 12;5(1):vdad060. doi: 10.1093/noajnl/vdad060. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37287694 Free PMC article.
Determinants of long-term survival in patients with IDH-mutant gliomas.
Katzendobler S, Niedermeyer S, Blobner J, Trumm C, Harter PN, von Baumgarten L, Stoecklein VM, Tonn JC, Weller M, Thon N, Weller J. Katzendobler S, et al. Among authors: harter pn. J Neurooncol. 2024 Dec;170(3):655-664. doi: 10.1007/s11060-024-04826-9. Epub 2024 Sep 24. J Neurooncol. 2024. PMID: 39316316 Free PMC article.
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments.
Müller KJ, Forbrig R, Reis J, Wiegand L, Barci E, Kunte SC, Kaiser L, Schönecker S, Schichor C, Harter PN, Thon N, von Baumgarten L, Preusser M, Albert NL. Müller KJ, et al. Among authors: harter pn. Neuro Oncol. 2025 Jan 12;27(1):77-88. doi: 10.1093/neuonc/noae208. Neuro Oncol. 2025. PMID: 39561103
Flip-flop phenomenon on dual SSTR PET and amino acid PET in a case of recurrent meningioma with malignant transformation.
Holzgreve A, Harter PN, Forbrig R, Quach S, Thon N, Schichor C, Tonn JC, Niyazi M, Brendel M, von Baumgarten L, Albert NL. Holzgreve A, et al. Among authors: harter pn. Eur J Nucl Med Mol Imaging. 2024 Nov 26. doi: 10.1007/s00259-024-06998-y. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39589520 No abstract available.
200 results